Hemodialysis Services Market Size, Share and Global Trend By Type (Home-Based Hemodialysis, In-Centre Hemodialysis), and Regional Forecast, 2024-2032

In 2016, two major players in kidney disease service, Baxter and Satellite Healthcare, announced an agreement to provide access to thousands of U.S. patients to the most advanced technologies in order to improve and personalize dialysis care. The growing prevalence of chronic kidney disease and end-stage renal disease is increasing exponentially across the globe.

According to Fresenius Medical Care, the prevalence of chronic kidney care is expected to grow by an estimated 6.5% by 2023. In order to deal with the increasing prevalence of chronic kidney failure, leading market players in the healthcare domain are taking initiatives to offer improved patient care. In April 2018, CVS Healthcare launched an initiative with an aim to spread awareness about early diagnosis of chronic kidney disease and the expansion of home dialysis for optimizing patient care. 

The rapidly growing prevalence of the end-stage renal disease is projected to offer huge growth opportunity for the global Hemodialysis Services Market during the forecast period. Additionally, the rise in prevalence of risk factors associated with the end-stage renal diseases such as chronic kidney disease, diabetes, hypertension, and others are expected to increase the demand for hemodialysis services in forthcoming years. Moreover, lucrative reimbursement policies are expected to attract new market players to enter into the global hemodialysis services market. 

The gradual shift of patient preference toward peritoneal dialysis due to higher patient convenience is anticipated to restrain the growth of the global hemodialysis services market.               

Key Players Covered 

Major companies that are present in the global hemodialysis services market are Fresenius Medical Care AG & Co. KGaA, DaVita Healthcare Partners, Inc., US Renal Care, Dialysis Clinic Inc., US Renal Association, Baxter International, Inc., Gambro AB, Diaverum, Nikkiso Co., Ltd., Nipro Corporation, NxStage Medical, Inc., MEDIVATORS, Inc., Satellite Healthcare Inc., and other players. 

 SEGMENTATION

Among the segmentation, in-center hemodialysis type is expected to hold a major share of the market owing to higher accessibility and better patient care. 

Key Insights 

• Overview of hemodialysis patients
• Key mergers and acquisitions
• Prevalence of end-stage renal disease
• Number of hemodialysis sessions in major countries 

Regional Analysis 

North America is anticipated to hold a considerable share in the global hemodialysis services market owing to the high prevalence of end-stage renal disease. Moreover, developed healthcare infrastructure, higher spending on kidney failure patients and valued patient care in North America is projected to boost the growth of the global hemodialysis services market. Asia Pacific is expected to register comparatively higher CAGR owing to the huge patient population and rapidly developing healthcare infrastructure. 

Key Industry Developments

• In October 2018, Baxter and Mayo Clinic agreed upon collaboration to establish renal care centre of excellence in the U.S., with aim to promote home dialysis, in-centre dialysis and to consult about chronic kidney disease management.
• In November 2018, NephroPlus announced the strategic plan to acquire 22 India based Da Vita Kidney centres.
• In December 2018, Fresenius Medical Care announced the plan to acquire dialysis centres in China with an aim to expand and strengthen its customer base in China hemodialysis market.
• In February 2019, Fresenius Medical Care completed the acquisition of NxStage Medical, Inc. in order to strengthen its product portfolio, especially in home-based hemodialysis machines.